大连标准化公共服务平台|国际技术法规

对委员会实施条例(EU) 2017/841的勘误，该条例关于修订实施条例(EU) No 540/2011，延长活性物质α-氯氰菊酯，白粉寄生孢菌株：水溶液10，苯霜灵，苯达松，联苯肼酯，溴草腈，氟酮唑草，氯苯胺灵，氰霜唑，甜菜安，敌草快，DPX KE 459（氟啶黄隆 - 甲基），乙螨唑，恶唑菌酮，

技术法规类型：欧盟Eurlex法规来源：tbtmap

EURLEX ID：32017R0841R(01)

OJ编号：OJ L 2, 5.1.2018, p. 14–14

中文标题：对委员会实施条例(EU) 2017/841的勘误，该条例关于修订实施条例(EU) No 540/2011，延长活性物质α-氯氰菊酯，白粉寄生孢菌株：水溶液10，苯霜灵，苯达松，联苯肼酯，溴草腈，氟酮唑草，氯苯胺灵，氰霜唑，甜菜安，敌草快，DPX KE 459（氟啶黄隆 - 甲基），乙螨唑，恶唑菌酮，咪唑菌酮，flumioxazine，甲酰胺磺隆，绿粘帚，catenulatum应变：j1446，甲氧咪草烟，咪唑磺隆，异恶唑草酮，昆布多糖，甲霜灵-M，甲氧，米尔螨素，环氧嘧磺隆，二甲戊乐灵，甜菜宁，吡蚜酮，S-异丙甲草胺，和肟菌酯的批准期限

原文标题：Corrigendum to Commission Implementing Regulation (EU) 2017/841 of 17 May 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, Ampelomyces quisqualis strain: aq 10, benalaxyl, bentazone, bifenazate, bromoxynil, carfentrazone ethyl, chlorpropham, cyazofamid, desmedipham, diquat, DPX KE 459 (flupyrsulfuron-methyl), etoxazole, famoxadone, fenamidone, flumioxazine, foramsulfuron, Gliocladium catenulatum strain: j1446, imazamox, imazosulfuron, isoxaflutole, laminarin, metalaxyl-m, methoxyfenozide, milbemectin, oxasulfuron, pendimethalin, phenmedipham, pymetrozine, s-metolachlor, and trifloxystrobin (OJ L 125, 18.5.2017)

法规全文：查看欧盟官方文件

5.1.2018

Official Journal of the European Union

L 2/14

Corrigendum to Commission Implementing Regulation (EU) 2017/841 of 17 May 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, Ampelomyces quisqualis strain: aq 10, benalaxyl, bentazone, bifenazate, bromoxynil, carfentrazone ethyl, chlorpropham, cyazofamid, desmedipham, diquat, DPX KE 459 (flupyrsulfuron-methyl), etoxazole, famoxadone, fenamidone, flumioxazine, foramsulfuron, Gliocladium catenulatum strain: j1446, imazamox, imazosulfuron, isoxaflutole, laminarin, metalaxyl-m, methoxyfenozide, milbemectin, oxasulfuron, pendimethalin, phenmedipham, pymetrozine, s-metolachlor, and trifloxystrobin

( Official Journal of the European Union L 125 of 18 May 2017 )

On the cover, in the table of contents, and on page 12, in the title:

for:

‘Commission Implementing Regulation (EU) 2017/841 of 17 May 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, Ampelomyces quisqualis strain: aq 10, benalaxyl, bentazone, bifenazate, bromoxynil, carfentrazone ethyl, chlorpropham, cyazofamid, desmedipham, diquat, DPX KE 459 (flupyrsulfuron-methyl), etoxazole, famoxadone, fenamidone, flumioxazine, foramsulfuron, Gliocladium catenulatum strain: j1446, imazamox, imazosulfuron, isoxaflutole, laminarin, metalaxyl-m, methoxyfenozide, milbemectin, oxasulfuron, pendimethalin, phenmedipham, pymetrozine, s-metolachlor, and trifloxystrobin’,

read:

‘Commission Implementing Regulation (EU) 2017/841 of 17 May 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, Ampelomyces quisqualis strain: aq 10, benalaxyl, bentazone, bifenazate, bromoxynil, carfentrazone ethyl, chlorpropham, cyazofamid, desmedipham, diquat, DPX KE 459 (flupyrsulfuron-methyl), etoxazole, famoxadone, fenamidone, flumioxazine, foramsulfuron, Gliocladium catenulatum strain: j1446, imazamox, isoxaflutole, laminarin, metalaxyl-m, methoxyfenozide, milbemectin, oxasulfuron, pendimethalin, phenmedipham, pymetrozine, s-metolachlor, and trifloxystrobin’;

on page 12, in recital 4:

for:

‘The approval periods of the active substances alpha-cypermethrin, Ampelomyces quisqualis strain: aq 10, benalaxyl, bifenazate, bromoxynil, chlorpropham, desmedipham, etoxazole, Gliocladium catenulatum strain: j1446, imazosulfuron, laminarin, methoxyfenozide, milbemectin, phenmedipham, and s-metolachlor were extended by Commission Implementing Regulation (EU) No 1197/2012 (7). The approval of those substances will expire on 31 July 2017.’,

read:

‘The approval periods of the active substances alpha-cypermethrin, Ampelomyces quisqualis strain: aq 10, benalaxyl, bifenazate, bromoxynil, chlorpropham, desmedipham, etoxazole, Gliocladium catenulatum strain: j1446, laminarin, methoxyfenozide, milbemectin, phenmedipham, and s-metolachlor were extended by Commission Implementing Regulation (EU) No 1197/2012 (7). The approval of those substances will expire on 31 July 2017.’.

附件:

P020180428361376226347.pdf
P020180428361376486335.html